EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effective Reduction of Transgene‐Specific Immune Response With rAAV Vectors Co‐Expressing miRNA ‐ UL112 ‐5p or ERAP1 shRNA

Xiaoping Huang iD, Xiao Wang, Yaqi Sun, Xinrui Xie, Luming Xiao, Yihang Xu, Qiongshi Yan, Xianxiang Xu, Ling Li, Wentao Xu, Wenting Weng, Wenlin Wu und 3 weitere

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70308 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Xiaoping Huang und 14 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemical Engineering and Materials Sciences, Quanzhou Normal University, Quanzhou, China. Hauptthemen laut MEDLINE: MicroRNAs, Dependovirus, Aminopeptidases, Genetic Vectors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, College Student Innovation and Entrepreneurship Training Program, Natural Science Foundation of the Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recombinant adeno‐associated virus (rAAV) has emerged as one of the best gene delivery vectors for human gene therapy in vivo. However, the clinical efficacy of rAAV gene therapy is often hindered by the host immune response against its transgene products. Endoplasmic reticulum aminopeptidase 1 (ERAP1) is specialised to process peptides presented by class I molecules of major histocompatibility complex. Therefore, we hypothesise that modulation of the ERAP1 activity in rAAV transduced cells may be favoured to evade immune response against transgene products. In this study, we incorporated either miRNA‐UL112‐5p or ERAP1 shRNA into rAAV vectors expressing full‐length ovalbumin (OVA) as a model antigen, and evaluated their effects for antigen presentation, cellular and humour immune response induced by OVA expression. The results indicated that silencing ERAP1 using miR‐UL112‐5p or ERAP1 shRNA did not affect the expression of OVA in cells, but inhibited the processing and presentation of OVA antigen peptide SIINFEKL in antigen presenting cells (APCs). Moreover, the rAAV vector co‐expressing ERAP1 shRNA maintains stable and high expression of OVA in vivo, while simultaneously suppressing the humoral immunity of OVA. In addition, experimental results demonstrated that rAAV vectors incorporated ERAP1 shRNA efficiently repress costimulatory signals in dendritic cells (DCs), significantly attenuated the cytotoxic T‐cell response, allowed for sustained transgene expression and reduced clearance of transduced muscle cells in mice. Moreover, our study suggested that the incorporation of miRNA‐UL112‐5p or ERAP1 shRNA into rAAV vectors effectively reduced transgene products induced immune response. The proposed method may potentially be applied in clinics to deliver therapeutic proteins safely and efficiently.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDependovirusAminopeptidasesGenetic VectorsMinor Histocompatibility AntigensTransgenesRNA, Small InterferingAnimalsOvalbuminHumansMiceAntigen PresentationMice, Inbred C57BLDendritic CellsAntigen-Presenting Cells

Stichwörter der Autor:innen

ERAP1immunitymiRNA‐UL‐112‐5prAAV

Substanzen

MicroRNAsAminopeptidasesMinor Histocompatibility AntigensOvalbuminRNA, Small InterferingERAP1 protein, human

Autor:innen und Institutionen

  • College of Chemical Engineering and Materials Sciences, Quanzhou Normal University, Quanzhou, China.
  • Institute of Molecular Medicine, Huaqiao University, Quanzhou, China.
  • College of Marine and Food Science, Quanzhou Normal University, Quanzhou, China.
  • Fujian Province Key Laboratory for the Development of Bioactive Material From Marine Algae, Quanzhou, China.

ORCID-Profile: Xiaoping Huang

Förderung

  • National Natural Science Foundation of China
  • College Student Innovation and Entrepreneurship Training Program
  • Natural Science Foundation of the Fujian Province
  • Fujian Provincial Association of Higher Education 2022 Higher Education Scientific Research Laboratory Research Special Project

Zitieren

APA

Huang, X., Wang, X., Sun, Y., Xie, X., Xiao, L., Xu, Y., Yan, Q., Xu, X., Li, L., Xu, W., Weng, W., Wu, W., Xie, X., Dai, C., & Diao, Y. (2025). Effective Reduction of Transgene‐Specific Immune Response With rAAV Vectors Co‐Expressing miRNA ‐ UL112 ‐5p or ERAP1 shRNA. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70308

Vancouver

Huang X, Wang X, Sun Y, Xie X, Xiao L, Xu Y, et al. Effective Reduction of Transgene‐Specific Immune Response With rAAV Vectors Co‐Expressing miRNA ‐ UL112 ‐5p or ERAP1 shRNA. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70308

BibTeX
@article{Huang2025,
  author = {Huang, Xiaoping and Wang, Xiao and Sun, Yaqi and Xie, Xinrui and Xiao, Luming and Xu, Yihang and Yan, Qiongshi and Xu, Xianxiang and Li, Ling and Xu, Wentao and Weng, Wenting and Wu, Wenlin and Xie, Xiaolan and Dai, Congjie and Diao, Yong},
  title = {Effective Reduction of Transgene‐Specific Immune Response With rAAV Vectors Co‐Expressing miRNA ‐ UL112 ‐5p or ERAP1 shRNA},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70308}
}
Kostenlos starten →